Cord Blood Transplant
Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 54 patients (estimated)
- Sponsors
- Memorial Sloan Kettering Cancer Center
- Tags
- Allogeneic Stem Cell Transplant, Cord Blood
- Trial Type
- Treatment
- Last Update
- 1 week ago
- SparkCures ID
- 1874
- NCT Identifier
- NCT05884333
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.